US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US6713061B1
(en)
|
1996-03-12 |
2004-03-30 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
WO1997033904A1
(en)
|
1996-03-12 |
1997-09-18 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US7357927B2
(en)
|
1996-03-12 |
2008-04-15 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US7964190B2
(en)
|
1996-03-22 |
2011-06-21 |
Human Genome Sciences, Inc. |
Methods and compositions for decreasing T-cell activity
|
US6635743B1
(en)
|
1996-03-22 |
2003-10-21 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule II and methods of use
|
US6455040B1
(en)
|
1997-01-14 |
2002-09-24 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptor 5
|
EP0857782A3
(en)
*
|
1997-01-27 |
1999-12-22 |
Smithkline Beecham Corporation |
Novel mammalian DD-1 gene
|
US7452538B2
(en)
*
|
1997-01-28 |
2008-11-18 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
US8329179B2
(en)
*
|
1997-01-28 |
2012-12-11 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
US6433147B1
(en)
*
|
1997-01-28 |
2002-08-13 |
Human Genome Sciences, Inc. |
Death domain containing receptor-4
|
WO1998032856A1
(en)
*
|
1997-01-28 |
1998-07-30 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap02-l)
|
US7528239B1
(en)
*
|
1997-02-13 |
2009-05-05 |
Immunex Corporation |
Receptor that binds trail
|
US6072047A
(en)
|
1997-02-13 |
2000-06-06 |
Immunex Corporation |
Receptor that binds trail
|
US20080248046A1
(en)
*
|
1997-03-17 |
2008-10-09 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US20040136951A1
(en)
*
|
1997-03-17 |
2004-07-15 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
CA2644454A1
(en)
|
1997-03-17 |
1998-09-24 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US6872568B1
(en)
|
1997-03-17 |
2005-03-29 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5 antibodies
|
US20050233958A1
(en)
*
|
1997-03-17 |
2005-10-20 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US6506569B1
(en)
|
1997-05-30 |
2003-01-14 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR10
|
CA2292790A1
(en)
*
|
1997-05-30 |
1998-12-03 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor tr10
|
EP1015587B1
(en)
|
1997-09-18 |
2008-04-23 |
Genentech, Inc. |
DcR3 POLYPEPTIDE, A TNFR HOMOLOG
|
WO1999037684A1
(en)
|
1998-01-26 |
1999-07-29 |
Genentech, Inc. |
Antibodies to death receptor 4 (dr4) and uses thereof
|
US20040180049A1
(en)
*
|
1998-01-26 |
2004-09-16 |
Genentech, Inc. |
DR4 antibodies and uses thereof
|
AU2007200507B2
(en)
*
|
1998-01-26 |
2010-03-11 |
Genentech, Inc. |
Antibodies to death receptor 4 (DR4) and uses thereof
|
US20040120947A1
(en)
*
|
1998-01-26 |
2004-06-24 |
Genentech, Inc. |
DR4 antibodies and uses thereof
|
WO2001060397A1
(en)
|
2000-02-16 |
2001-08-23 |
Genentech, Inc. |
Uses of agonists and antagonists to modulate activity of tnf-related molecules
|
US20050281821A1
(en)
*
|
1999-01-06 |
2005-12-22 |
Flavia Pernasetti |
Method and composition for angiogenesis inhibition
|
JP2002537769A
(ja)
|
1999-02-26 |
2002-11-12 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
ヒトエンドカインαおよび使用方法
|
JP2003522118A
(ja)
*
|
1999-04-22 |
2003-07-22 |
ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド |
デスドメイン含有受容体
|
CA2373063A1
(en)
*
|
1999-05-06 |
2000-11-16 |
Jian Ni |
Death domain containing receptor 4
|
DE60042066D1
(de)
*
|
1999-05-28 |
2009-06-04 |
Genentech Inc |
Chimärische dr4 antikörper und ihre verwendung
|
AU6928200A
(en)
*
|
1999-08-25 |
2001-03-19 |
Genome Therapeutics Corporation |
A transmembrane trap for isolating membrane bound proteins
|
DK2857516T3
(da)
|
2000-04-11 |
2017-08-07 |
Genentech Inc |
Multivalente antistoffer og anvendelser herfor
|
CA2405557C
(en)
|
2000-04-12 |
2013-09-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
TWI318983B
(en)
|
2000-05-02 |
2010-01-01 |
Uab Research Foundation |
An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
|
US7279160B2
(en)
|
2000-05-02 |
2007-10-09 |
The Uab Research Foundation |
Combinations of DR5 antibodies and other therapeutic agents
|
US7476383B2
(en)
*
|
2000-05-02 |
2009-01-13 |
The Uab Research Foundation |
Antibody selective for DR4 and uses thereof
|
WO2001096528A2
(en)
|
2000-06-15 |
2001-12-20 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor delta and epsilon
|
WO2002002641A1
(en)
|
2000-06-16 |
2002-01-10 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to blys
|
JP2004509078A
(ja)
*
|
2000-07-27 |
2004-03-25 |
ジェネンテック・インコーポレーテッド |
Apo−2LレセプターアゴニストとCPT−11の相乗作用
|
US20060062786A1
(en)
*
|
2000-11-08 |
2006-03-23 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
WO2002079377A2
(en)
*
|
2000-11-08 |
2002-10-10 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
US20030228309A1
(en)
*
|
2000-11-08 |
2003-12-11 |
Theodora Salcedo |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20020155109A1
(en)
*
|
2001-04-20 |
2002-10-24 |
Lynch David H. |
Bispecific antibodies that bind TRAIL-R1 and TRAIL-R2
|
JP3665316B2
(ja)
*
|
2001-05-18 |
2005-06-29 |
麒麟麦酒株式会社 |
抗trail−r抗体
|
US7361341B2
(en)
*
|
2001-05-25 |
2008-04-22 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
|
US20050129616A1
(en)
*
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20090226429A1
(en)
*
|
2001-05-25 |
2009-09-10 |
Human Genome Sciences, Inc. |
Antibodies That Immunospecifically Bind to TRAIL Receptors
|
US20050214209A1
(en)
*
|
2001-05-25 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US7348003B2
(en)
|
2001-05-25 |
2008-03-25 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
|
WO2002097033A2
(en)
*
|
2001-05-25 |
2002-12-05 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
EP2192130A1
(en)
*
|
2001-07-03 |
2010-06-02 |
Genentech, Inc. |
Human DR4 antibodies and uses thereof
|
WO2003013584A1
(en)
*
|
2001-08-09 |
2003-02-20 |
Genset S.A. |
Xafinix agonists and antagonists for use in the treatment of metabolic disorders
|
ES2357225T3
(es)
*
|
2001-11-01 |
2011-04-20 |
Uab Research Foundation |
Combinaciones de anticuerpos anti-dr5 y anticuerpos anti-dr4 y otros agentes terapéuticos.
|
US7741285B2
(en)
|
2001-11-13 |
2010-06-22 |
Genentech, Inc. |
APO-2 ligand/trail formulations
|
EP2332531B1
(en)
|
2001-11-13 |
2019-07-10 |
Genentech, Inc. |
Methods of purifying Apo2-Ligand/TRAIL
|
US7842668B1
(en)
|
2001-11-13 |
2010-11-30 |
Genentech, Inc. |
Apo-2 ligand/trail formulations
|
JP2005516958A
(ja)
*
|
2001-12-20 |
2005-06-09 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
Trailレセプターに免疫特異的に結合する抗体
|
EP2261250B1
(en)
|
2001-12-21 |
2015-07-01 |
Human Genome Sciences, Inc. |
GCSF-Albumin fusion proteins
|
AU2003269884A1
(en)
*
|
2002-05-22 |
2003-12-22 |
Incyte Corporation |
Receptors and membrane-associated proteins
|
CA2489348A1
(en)
|
2002-06-24 |
2003-12-31 |
Genentech, Inc. |
Apo-2 ligand/trail variants and uses thereof
|
US7902338B2
(en)
|
2003-07-31 |
2011-03-08 |
Immunomedics, Inc. |
Anti-CD19 antibodies
|
CA2938411C
(en)
|
2003-09-12 |
2019-03-05 |
Minnow Medical, Llc |
Selectable eccentric remodeling and/or ablation of atherosclerotic material
|
JP2007513611A
(ja)
*
|
2003-11-26 |
2007-05-31 |
ザ クイーンズ ユニヴァーシティ オブ ベルファスト |
癌治療
|
US7892539B2
(en)
*
|
2004-03-24 |
2011-02-22 |
The Regents Of The University Of California |
Modulation of an innate immune response by altering TRIAL-R signaling
|
US20080260763A1
(en)
*
|
2004-07-01 |
2008-10-23 |
The Regents Of The University Of California |
High Throughput Proteomics
|
CN101061238B
(zh)
*
|
2004-08-06 |
2013-11-20 |
健泰科生物技术公司 |
使用生物标志的测定法和方法
|
JP5237638B2
(ja)
|
2004-08-06 |
2013-07-17 |
ジェネンテック, インコーポレイテッド |
バイオマーカーを用いたアッセイおよび方法
|
AU2005282397A1
(en)
*
|
2004-09-08 |
2006-03-16 |
Genentech, Inc. |
Methods of using death receptor ligands and CD20 antibodies
|
EP1791864A2
(en)
*
|
2004-09-08 |
2007-06-06 |
Genentech, Inc. |
Methods of using death receptor ligands and cd20 antibodies
|
US8396548B2
(en)
|
2008-11-14 |
2013-03-12 |
Vessix Vascular, Inc. |
Selective drug delivery in a lumen
|
US9713730B2
(en)
|
2004-09-10 |
2017-07-25 |
Boston Scientific Scimed, Inc. |
Apparatus and method for treatment of in-stent restenosis
|
JO3000B1
(ar)
*
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
US8029783B2
(en)
|
2005-02-02 |
2011-10-04 |
Genentech, Inc. |
DR5 antibodies and articles of manufacture containing same
|
WO2006083937A2
(en)
|
2005-02-02 |
2006-08-10 |
The Uab Research Foundation |
Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
|
US20090155247A1
(en)
*
|
2005-02-18 |
2009-06-18 |
Ashkenazi Avi J |
Methods of Using Death Receptor Agonists and EGFR Inhibitors
|
ATE533058T1
(de)
*
|
2005-08-16 |
2011-11-15 |
Genentech Inc |
Apoptosesensitivität gegenüber apo2l/trail mittels testen auf galnac-t14-expression in zellen/gewebe
|
WO2007024921A2
(en)
*
|
2005-08-24 |
2007-03-01 |
Cell Matrix |
Combination therapies for inhibiting integrin-extracellular matrix interactions
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
NZ568204A
(en)
|
2005-10-13 |
2012-01-12 |
Human Genome Sciences Inc |
Methods and compositions for use in treatment of patients with autoantibody positive diseases
|
JP6088723B2
(ja)
|
2005-11-23 |
2017-03-01 |
ジェネンテック, インコーポレイテッド |
B細胞アッセイに関する組成物及び方法。
|
US8019435B2
(en)
|
2006-05-02 |
2011-09-13 |
Boston Scientific Scimed, Inc. |
Control of arterial smooth muscle tone
|
AU2007310986B2
(en)
|
2006-10-18 |
2013-07-04 |
Boston Scientific Scimed, Inc. |
Inducing desirable temperature effects on body tissue
|
EP2455034B1
(en)
|
2006-10-18 |
2017-07-19 |
Vessix Vascular, Inc. |
System for inducing desirable temperature effects on body tissue
|
EP2076193A4
(en)
|
2006-10-18 |
2010-02-03 |
Minnow Medical Inc |
MATCHED RF-ENERGY AND ELECTRO-TISSUE CHARACTERIZATION FOR THE SELECTIVE TREATMENT OF TARGET TISSUE
|
US9297803B2
(en)
*
|
2006-11-01 |
2016-03-29 |
Immport Therapeutics, Inc. |
Compositions and methods for immunodominant antigens
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
DK2257301T3
(da)
|
2008-03-03 |
2014-04-28 |
Univ Miami |
Immunterapi baseret på allogene cancerceller.
|
JP5771147B2
(ja)
|
2008-09-26 |
2015-08-26 |
トカジェン インコーポレーテッド |
遺伝子治療ベクターおよびシトシンデアミナーゼ
|
US20100105620A1
(en)
*
|
2008-10-10 |
2010-04-29 |
Anaphore, Inc. |
Polypeptides that bind Trail-R1 and Trail-R2
|
CN102271603A
(zh)
|
2008-11-17 |
2011-12-07 |
明诺医学股份有限公司 |
得知或未得知组织形态的选择性能量积累
|
LT3912643T
(lt)
|
2009-02-13 |
2023-02-10 |
Immunomedics Inc. |
Imunokonjugatai su ląstelės viduje skaldoma jungtimi
|
CN102482701B
(zh)
|
2009-09-16 |
2015-05-13 |
免疫医疗公司 |
I类抗-cea抗体及其使用
|
CA2777162A1
(en)
*
|
2009-10-09 |
2011-04-14 |
Anaphore, Inc. |
Polypeptides that bind il-23r
|
CN102666588A
(zh)
|
2009-11-05 |
2012-09-12 |
Uab研究基金会 |
治疗基底细胞样基因型癌症
|
WO2011068845A1
(en)
|
2009-12-02 |
2011-06-09 |
Immunomedics, Inc. |
Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
|
WO2011116344A2
(en)
|
2010-03-18 |
2011-09-22 |
The Uab Research Foundation |
Targeting cancer stem cells
|
KR20130108067A
(ko)
|
2010-04-09 |
2013-10-02 |
베식스 바스큘라 인코포레이티드 |
조직 치료를 위한 발전 및 제어 장치
|
US9192790B2
(en)
|
2010-04-14 |
2015-11-24 |
Boston Scientific Scimed, Inc. |
Focused ultrasonic renal denervation
|
AU2011252841B2
(en)
|
2010-05-14 |
2014-04-03 |
Amgen Inc. |
Enhanced death receptor agonists
|
US8473067B2
(en)
|
2010-06-11 |
2013-06-25 |
Boston Scientific Scimed, Inc. |
Renal denervation and stimulation employing wireless vascular energy transfer arrangement
|
CA2802349A1
(en)
*
|
2010-06-16 |
2011-12-22 |
The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services |
Anti-dr4 agonist antibodies
|
US9463062B2
(en)
|
2010-07-30 |
2016-10-11 |
Boston Scientific Scimed, Inc. |
Cooled conductive balloon RF catheter for renal nerve ablation
|
US9408661B2
(en)
|
2010-07-30 |
2016-08-09 |
Patrick A. Haverkost |
RF electrodes on multiple flexible wires for renal nerve ablation
|
US9084609B2
(en)
|
2010-07-30 |
2015-07-21 |
Boston Scientific Scime, Inc. |
Spiral balloon catheter for renal nerve ablation
|
US9358365B2
(en)
|
2010-07-30 |
2016-06-07 |
Boston Scientific Scimed, Inc. |
Precision electrode movement control for renal nerve ablation
|
US9155589B2
(en)
|
2010-07-30 |
2015-10-13 |
Boston Scientific Scimed, Inc. |
Sequential activation RF electrode set for renal nerve ablation
|
EP2625577B1
(en)
|
2010-10-08 |
2019-06-26 |
Terumo BCT, Inc. |
Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
US8974451B2
(en)
|
2010-10-25 |
2015-03-10 |
Boston Scientific Scimed, Inc. |
Renal nerve ablation using conductive fluid jet and RF energy
|
US9220558B2
(en)
|
2010-10-27 |
2015-12-29 |
Boston Scientific Scimed, Inc. |
RF renal denervation catheter with multiple independent electrodes
|
US9028485B2
(en)
|
2010-11-15 |
2015-05-12 |
Boston Scientific Scimed, Inc. |
Self-expanding cooling electrode for renal nerve ablation
|
US9668811B2
(en)
|
2010-11-16 |
2017-06-06 |
Boston Scientific Scimed, Inc. |
Minimally invasive access for renal nerve ablation
|
US9089350B2
(en)
|
2010-11-16 |
2015-07-28 |
Boston Scientific Scimed, Inc. |
Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
|
US9326751B2
(en)
|
2010-11-17 |
2016-05-03 |
Boston Scientific Scimed, Inc. |
Catheter guidance of external energy for renal denervation
|
US9060761B2
(en)
|
2010-11-18 |
2015-06-23 |
Boston Scientific Scime, Inc. |
Catheter-focused magnetic field induced renal nerve ablation
|
EP2640744A4
(en)
|
2010-11-19 |
2014-05-28 |
Eisai R&D Man Co Ltd |
NEUTRALIZATION OF ANTIBODIES TO CCL20
|
US9023034B2
(en)
|
2010-11-22 |
2015-05-05 |
Boston Scientific Scimed, Inc. |
Renal ablation electrode with force-activatable conduction apparatus
|
US9192435B2
(en)
|
2010-11-22 |
2015-11-24 |
Boston Scientific Scimed, Inc. |
Renal denervation catheter with cooled RF electrode
|
US20120157993A1
(en)
|
2010-12-15 |
2012-06-21 |
Jenson Mark L |
Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
|
WO2012100095A1
(en)
|
2011-01-19 |
2012-07-26 |
Boston Scientific Scimed, Inc. |
Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
|
US20140105898A1
(en)
|
2011-02-28 |
2014-04-17 |
Istituto Di Ricovero E Cura A Carattere Scientific Materno-Infantile Burlo Garo |
Apoptosis-inducing molecules and uses therefor
|
CA2831572C
(en)
|
2011-05-02 |
2019-11-26 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
WO2012151317A1
(en)
|
2011-05-03 |
2012-11-08 |
Genentech, Inc. |
Vascular disruption agents and uses thereof
|
WO2013013156A2
(en)
|
2011-07-20 |
2013-01-24 |
Boston Scientific Scimed, Inc. |
Percutaneous devices and methods to visualize, target and ablate nerves
|
JP6106669B2
(ja)
|
2011-07-22 |
2017-04-05 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
ヘリカル・ガイド内に配置可能な神経調節要素を有する神経調節システム
|
WO2013055826A1
(en)
|
2011-10-10 |
2013-04-18 |
Boston Scientific Scimed, Inc. |
Medical devices including ablation electrodes
|
WO2013055815A1
(en)
|
2011-10-11 |
2013-04-18 |
Boston Scientific Scimed, Inc. |
Off -wall electrode device for nerve modulation
|
US9420955B2
(en)
|
2011-10-11 |
2016-08-23 |
Boston Scientific Scimed, Inc. |
Intravascular temperature monitoring system and method
|
US9364284B2
(en)
|
2011-10-12 |
2016-06-14 |
Boston Scientific Scimed, Inc. |
Method of making an off-wall spacer cage
|
US9079000B2
(en)
|
2011-10-18 |
2015-07-14 |
Boston Scientific Scimed, Inc. |
Integrated crossing balloon catheter
|
WO2013058962A1
(en)
|
2011-10-18 |
2013-04-25 |
Boston Scientific Scimed, Inc. |
Deflectable medical devices
|
CN108095821B
(zh)
|
2011-11-08 |
2021-05-25 |
波士顿科学西美德公司 |
孔部肾神经消融
|
EP2779929A1
(en)
|
2011-11-15 |
2014-09-24 |
Boston Scientific Scimed, Inc. |
Device and methods for renal nerve modulation monitoring
|
US9119632B2
(en)
|
2011-11-21 |
2015-09-01 |
Boston Scientific Scimed, Inc. |
Deflectable renal nerve ablation catheter
|
US9265969B2
(en)
|
2011-12-21 |
2016-02-23 |
Cardiac Pacemakers, Inc. |
Methods for modulating cell function
|
CA2859989C
(en)
|
2011-12-23 |
2020-03-24 |
Vessix Vascular, Inc. |
Methods and apparatuses for remodeling tissue of or adjacent to a body passage
|
CN104135958B
(zh)
|
2011-12-28 |
2017-05-03 |
波士顿科学西美德公司 |
用有聚合物消融元件的新消融导管调变神经的装置和方法
|
US9050106B2
(en)
|
2011-12-29 |
2015-06-09 |
Boston Scientific Scimed, Inc. |
Off-wall electrode device and methods for nerve modulation
|
CA2867631C
(en)
|
2012-03-28 |
2019-06-11 |
Amgen Inc. |
Dr5 receptor agonist combinations
|
US10660703B2
(en)
|
2012-05-08 |
2020-05-26 |
Boston Scientific Scimed, Inc. |
Renal nerve modulation devices
|
EP2684896A1
(en)
|
2012-07-09 |
2014-01-15 |
International-Drug-Development-Biotech |
Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies and methods of use thereof
|
CN104379169A
(zh)
|
2012-08-14 |
2015-02-25 |
Ibc药品公司 |
用于治疗疾病的t-细胞重定向双特异性抗体
|
WO2014032016A1
(en)
|
2012-08-24 |
2014-02-27 |
Boston Scientific Scimed, Inc. |
Intravascular catheter with a balloon comprising separate microporous regions
|
CN104780859B
(zh)
|
2012-09-17 |
2017-07-25 |
波士顿科学西美德公司 |
用于肾神经调节的自定位电极系统及方法
|
US10398464B2
(en)
|
2012-09-21 |
2019-09-03 |
Boston Scientific Scimed, Inc. |
System for nerve modulation and innocuous thermal gradient nerve block
|
US10549127B2
(en)
|
2012-09-21 |
2020-02-04 |
Boston Scientific Scimed, Inc. |
Self-cooling ultrasound ablation catheter
|
JP6074051B2
(ja)
|
2012-10-10 |
2017-02-01 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
血管内神経変調システム及び医療用デバイス
|
JP6419706B2
(ja)
|
2012-10-25 |
2018-11-07 |
トカジェン インコーポレーテッド |
ミニプロモーターカセットを含むレトロウイルスベクター
|
SI2900277T1
(sl)
|
2012-12-13 |
2022-05-31 |
Immunomedics, Inc. |
Odmerki imunokonjugatov protiteles in SN-38 za boljšo učinkovitost in zmanjšano toksičnost
|
US9956033B2
(en)
|
2013-03-11 |
2018-05-01 |
Boston Scientific Scimed, Inc. |
Medical devices for modulating nerves
|
US9693821B2
(en)
|
2013-03-11 |
2017-07-04 |
Boston Scientific Scimed, Inc. |
Medical devices for modulating nerves
|
US9808311B2
(en)
|
2013-03-13 |
2017-11-07 |
Boston Scientific Scimed, Inc. |
Deflectable medical devices
|
EP2970473B1
(en)
|
2013-03-14 |
2017-08-16 |
Bristol-Myers Squibb Company |
Combination of dr5 agonist and anti-pd-1 antagonist and methods of use
|
US9297845B2
(en)
|
2013-03-15 |
2016-03-29 |
Boston Scientific Scimed, Inc. |
Medical devices and methods for treatment of hypertension that utilize impedance compensation
|
EP2967734B1
(en)
|
2013-03-15 |
2019-05-15 |
Boston Scientific Scimed, Inc. |
Methods and apparatuses for remodeling tissue of or adjacent to a body passage
|
US10265122B2
(en)
|
2013-03-15 |
2019-04-23 |
Boston Scientific Scimed, Inc. |
Nerve ablation devices and related methods of use
|
US10022182B2
(en)
|
2013-06-21 |
2018-07-17 |
Boston Scientific Scimed, Inc. |
Medical devices for renal nerve ablation having rotatable shafts
|
CN105473091B
(zh)
|
2013-06-21 |
2020-01-21 |
波士顿科学国际有限公司 |
具有可一起移动的电极支撑件的肾脏去神经球囊导管
|
US9707036B2
(en)
|
2013-06-25 |
2017-07-18 |
Boston Scientific Scimed, Inc. |
Devices and methods for nerve modulation using localized indifferent electrodes
|
US9833283B2
(en)
|
2013-07-01 |
2017-12-05 |
Boston Scientific Scimed, Inc. |
Medical devices for renal nerve ablation
|
WO2015006480A1
(en)
|
2013-07-11 |
2015-01-15 |
Boston Scientific Scimed, Inc. |
Devices and methods for nerve modulation
|
WO2015006573A1
(en)
|
2013-07-11 |
2015-01-15 |
Boston Scientific Scimed, Inc. |
Medical device with stretchable electrode assemblies
|
US9925001B2
(en)
|
2013-07-19 |
2018-03-27 |
Boston Scientific Scimed, Inc. |
Spiral bipolar electrode renal denervation balloon
|
JP2016527959A
(ja)
|
2013-07-22 |
2016-09-15 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
腎神経アブレーション用医療器具
|
EP3024405A1
(en)
|
2013-07-22 |
2016-06-01 |
Boston Scientific Scimed, Inc. |
Renal nerve ablation catheter having twist balloon
|
WO2015027096A1
(en)
|
2013-08-22 |
2015-02-26 |
Boston Scientific Scimed, Inc. |
Flexible circuit having improved adhesion to a renal nerve modulation balloon
|
US9895194B2
(en)
|
2013-09-04 |
2018-02-20 |
Boston Scientific Scimed, Inc. |
Radio frequency (RF) balloon catheter having flushing and cooling capability
|
EP3043733A1
(en)
|
2013-09-13 |
2016-07-20 |
Boston Scientific Scimed, Inc. |
Ablation balloon with vapor deposited cover layer
|
EP3057488B1
(en)
|
2013-10-14 |
2018-05-16 |
Boston Scientific Scimed, Inc. |
High resolution cardiac mapping electrode array catheter
|
US11246654B2
(en)
|
2013-10-14 |
2022-02-15 |
Boston Scientific Scimed, Inc. |
Flexible renal nerve ablation devices and related methods of use and manufacture
|
US9770606B2
(en)
|
2013-10-15 |
2017-09-26 |
Boston Scientific Scimed, Inc. |
Ultrasound ablation catheter with cooling infusion and centering basket
|
AU2014334574B2
(en)
|
2013-10-15 |
2017-07-06 |
Boston Scientific Scimed, Inc. |
Medical device balloon
|
CN105636538B
(zh)
|
2013-10-18 |
2019-01-15 |
波士顿科学国际有限公司 |
具有柔性导线的球囊导管及其使用和制造的相关方法
|
JP2016534842A
(ja)
|
2013-10-25 |
2016-11-10 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
除神経フレックス回路における埋め込み熱電対
|
JP6633522B2
(ja)
|
2013-11-16 |
2020-01-22 |
テルモ ビーシーティー、インコーポレーテッド |
バイオリアクターにおける細胞増殖
|
JP6382989B2
(ja)
|
2014-01-06 |
2018-08-29 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
耐引き裂き性フレキシブル回路アセンブリを備える医療デバイス
|
US10322173B2
(en)
|
2014-01-15 |
2019-06-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
US9907609B2
(en)
|
2014-02-04 |
2018-03-06 |
Boston Scientific Scimed, Inc. |
Alternative placement of thermal sensors on bipolar electrode
|
US11000679B2
(en)
|
2014-02-04 |
2021-05-11 |
Boston Scientific Scimed, Inc. |
Balloon protection and rewrapping devices and related methods of use
|
ES2978993T3
(es)
|
2014-02-21 |
2024-09-23 |
Ibc Pharmaceuticals Inc |
Terapia de enfermedades mediante la inducción de la respuesta inmunitaria a las células que expresan Trop-2
|
EP3110445A4
(en)
|
2014-02-25 |
2017-09-27 |
Immunomedics, Inc. |
Humanized rfb4 anti-cd22 antibody
|
WO2015138638A1
(en)
|
2014-03-11 |
2015-09-17 |
Theraly Pharmaceuticals, Inc. |
Long acting trail receptor agonists for treatment of autoimmune diseases
|
WO2015148704A1
(en)
|
2014-03-25 |
2015-10-01 |
Terumo Bct, Inc. |
Passive replacement of media
|
US9580495B2
(en)
|
2014-06-24 |
2017-02-28 |
Immunomedics, Inc. |
Anti-histone therapy for vascular necrosis in severe glomerulonephritis
|
WO2016049421A1
(en)
|
2014-09-26 |
2016-03-31 |
Terumo Bct, Inc. |
Scheduled feed
|
EP3204018B1
(en)
|
2014-10-07 |
2021-08-25 |
Immunomedics, Inc. |
Neoadjuvant use of antibody-drug conjugates
|
CN107428837A
(zh)
|
2015-04-22 |
2017-12-01 |
免疫医疗公司 |
循环trop‑2阳性癌细胞的分离、检测、诊断和/或鉴定
|
JP6980980B2
(ja)
|
2015-06-25 |
2021-12-15 |
イミューノメディクス、インコーポレイテッドImmunomedics, Inc. |
抗hla‐drまたは抗trop‐2抗体と微小管阻害剤、parp阻害剤、ブルトンキナーゼ阻害剤またはホスホイノシチド3‐キナーゼ阻害剤との併用は癌の治療効果を有意に改善する
|
EP3316885B1
(en)
|
2015-07-01 |
2021-06-23 |
Immunomedics, Inc. |
Antibody-sn-38 immunoconjugates with a cl2a linker
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
MA43365A
(fr)
|
2015-12-01 |
2018-10-10 |
Genmab Bv |
Anticorps anti-dr5 et procédés d'utilisation de ceux-ci
|
AU2016371021B2
(en)
|
2015-12-17 |
2020-04-09 |
The Johns Hopkins University |
Ameliorating systemic sclerosis with death receptor agonists
|
KR102508650B1
(ko)
|
2016-04-07 |
2023-03-13 |
더 존스 홉킨스 유니버시티 |
사멸 수용체 작용제로써 췌장암 및 통증을 치료하기 위한 조성물 및 방법
|
US11965175B2
(en)
|
2016-05-25 |
2024-04-23 |
Terumo Bct, Inc. |
Cell expansion
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
CN106243215B
(zh)
*
|
2016-08-17 |
2019-09-03 |
哈尔滨医科大学 |
一种人trail i型受体激动性抗原表位多肽及其抗体和应用
|
EP3323428A1
(en)
|
2016-11-17 |
2018-05-23 |
CNRS Centre National de la Recherche Scientifique |
Selective c-flip inhibitors as anticancer agents
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
EP3656841A1
(en)
|
2017-03-31 |
2020-05-27 |
Terumo BCT, Inc. |
Cell expansion
|
EP3910331A1
(en)
|
2020-05-15 |
2021-11-17 |
iOmx Therapeutics AG |
Intracellular kinase associated with resistance against t-cell mediated cytotoxicity, and uses thereof
|
US11767353B2
(en)
|
2020-06-05 |
2023-09-26 |
Theraly Fibrosis, Inc. |
Trail compositions with reduced immunogenicity
|
US12043823B2
(en)
|
2021-03-23 |
2024-07-23 |
Terumo Bct, Inc. |
Cell capture and expansion
|
WO2022239720A1
(ja)
|
2021-05-10 |
2022-11-17 |
公益財団法人川崎市産業振興財団 |
抗原への結合親和性を低減させた抗体
|
EP4257132A1
(en)
|
2022-04-08 |
2023-10-11 |
iOmx Therapeutics AG |
Sik3 inhibitors for treating diseases resistant to death receptor signalling
|
WO2024175554A1
(en)
|
2023-02-21 |
2024-08-29 |
Institut Curie |
Trail agonists for use in the treatment of cancer in patients having an activating alteration of fgfr3
|